Literature DB >> 48897

Morbidity and mortality in pseudopolycythaemia.

P S Burge, W S Johnson, T A Prankerd.   

Abstract

A follow-up of 35 patients with pseudopolycythaemia showed that symptoms, high packed-cell volumes, and low plasma volumes persisted in most patients. The death-rate in these patients was six times greater than expected. Patients with pseudopolycythaemia are often regarded as having a good prognosis; however, this view should be revised in the light of these findings.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48897     DOI: 10.1016/s0140-6736(75)92551-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

Review 1.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

2.  Relative erythrocytosis: an approach to the patient.

Authors:  F A Lederle
Journal:  J Gen Intern Med       Date:  1987 Mar-Apr       Impact factor: 5.128

3.  Erythrapheresis in polycythemia.

Authors:  R J Gregory
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-26

4.  [Acute myocardial infarct caused by nicotine-induced erythrocytosis].

Authors:  S Andreas; K S Herrmann; H Kreuzer; V Wiegand
Journal:  Klin Wochenschr       Date:  1989-10-02

5.  The perioperative management of patients with polycythaemia.

Authors:  J Cundy
Journal:  Ann R Coll Surg Engl       Date:  1980-11       Impact factor: 1.891

6.  Smoking--a major cause of polycythaemia.

Authors:  R Aitchison; N Russell
Journal:  J R Soc Med       Date:  1988-02       Impact factor: 18.000

7.  Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk.

Authors:  Ma-Li Wong; Chuanhui Dong; Karin Esposito; Sarika Thakur; Weiqing Liu; Robert M Elashoff; Julio Licinio
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.